Znn3bq.jpeg
ÉÇÍ·´óѧº£Ñó¿ÆÑ§½ÓÊܵ÷¼Á
²é¿´: 733  |  »Ø¸´: 0

Yuga93

гæ (³õÈëÎÄ̳)

[ÇóÖú] ÇóÖú·­Òë ¹ØÓÚHIFºÍshRNA

ÇóÖú·­Ò룺
²ËÄñÒ»¸ö£¬Õâ¶ÎÓеã¸ã²»¶®×÷ÕßµÄÒâͼÊÇʲô¡£¡£¡£
To investigate the role of each of the HIF-a subunits in human
HSPCs, we constructed bicistronic lentiviral vectors carrying two
distinct promoters, EF1a and H1, driving green fluorescent pro-
tein (GFP) (reporter) and a small hairpin RNA (shRNA) against the
HIF-1a (sequence published in Rezvani et al., 2007) or HIF-2a
subunit, respectively (Figure S1B). To confirm the specificity
and efficiency of these vectors, CD34+ cells were transduced
(45%¨C80% transduction efficiency), FACS-sorted 4 days post-
transduction, and cultured for an additional 4 days prior to our
assessment of mRNA levels. A significant reduction in mRNA
levels was observed for both HIF-1a and HIF-2a vectors relative
to controls, with a decrease of 88% and 78%, respectively (Fig-
ure 1B). The KD was also confirmed at the protein level in CD34+
cells (Figure 1C) and in 293T cells (Figure S1C). The shHIF1a
used in this study has been previously validated elsewhere
(Rezvani et al., 2007). However, to confirm the specificity and
exclude off-target effects of the shRNA for HIF-2a, we tested a
second shHIF2a (shHIF2a.2) (Figure S1D). Using this second
vector, we confirmed an efficient KD at the protein level, as
well as similar defects in vivo compared to the first shRNA
used (shHIF2a.1) (Figure S1E). We then used the construct that
gave us the best silencing activity (shHIF2a.1) for the rest of
this study.
»¹Óй¹½¨µÄshRNA×÷ÓÃÊDz»ÊǾÍÊDZí´ïHIF1aºÍHIF2a£¿
ÏÂÓΰлùÒòµÄ±í´ï¼õÉÙÊÇ·ñÒâζ×ÅHIF1aºÍHIF2aµÄ±í´ï¼õÉÙ£¿
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ Yuga93 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 0856ר˶Çóµ÷¼Á Ï£ÍûÊÇaÇøÔºÐ£ +24 ºÃºÃÐÝÏ¢ºÃ²»ºÃ 2026-04-09 27/1350 2026-04-13 22:22 by pies112
[¿¼ÑÐ] 291 Çóµ÷¼Á +33 »¯¹¤2026½ì±ÏÒµÉ 2026-04-09 33/1650 2026-04-13 22:16 by pies112
[¿¼ÑÐ] 327Çóµ÷¼Á +21 Xxjc1107. 2026-04-13 23/1150 2026-04-13 21:53 by bljnqdcc
[¿¼ÑÐ] ²ÄÁϸ´ÊÔÇóµ÷¼Á +24 xhhdjdjsjks 2026-04-09 24/1200 2026-04-13 15:49 by ÐÒÃâ ..
[¿¼ÑÐ] 272·Ö²ÄÁÏ×ÓÇóµ÷¼Á +41 Loy0361 2026-04-10 53/2650 2026-04-13 14:20 by ÕÅzhihao
[¿¼ÑÐ] һ־Ը˫·Ç085400µç×ÓÐÅÏ¢344 Çóµ÷¼Á£¬¶Ô²ÄÁϺͻ¯Ñ§·½ÏòÒ²¸ÐÐËȤ +12 ÎÞÇéµÄСÑò 2026-04-09 13/650 2026-04-13 14:17 by ÕÅzhihao
[¿¼ÑÐ] ²ÄÁÏ299ר˶Çóµ÷¼Á +13 +21 2026-04-09 13/650 2026-04-13 14:16 by ÕÅzhihao
[¿¼ÑÐ] 346·Ö£¬¹¤¿Æ0854Çóµ÷¼Á£¬×¨Ë¶ +6 moser233 2026-04-12 7/350 2026-04-12 22:11 by fqwang
[¿¼ÑÐ] µç×ÓÐÅÏ¢270Çóµ÷¼Á +18 terminal469 2026-04-07 18/900 2026-04-12 16:23 by ajpv·çÀ×
[¿¼ÑÐ] 343Çóµ÷¼Á +9 Íõ¹ú˧ 2026-04-10 9/450 2026-04-11 20:31 by dongdian1
[¿¼ÑÐ] ±¾ÈËÅ®º¢ +7 ºðºð£¬ 2026-04-10 9/450 2026-04-11 14:45 by ACS Nano¡ª¡ª
[¿¼ÑÐ] Ò»Ö¾Ô¸985»úеѧ˶380Çóµ÷¼Á +5 ¹Ø¹ØöÂð¯10 2026-04-11 5/250 2026-04-11 10:10 by ÖªÄî¡£A
[¿¼ÑÐ] 293Çóµ÷¼Á +6 ÓÂÔ¶¿â°®314 2026-04-08 6/300 2026-04-11 10:08 by zhq0425
[¿¼ÑÐ] 368Çóµ÷¼Á +3 17385968172 2026-04-10 3/150 2026-04-10 20:12 by µç×Ӱµ±ë
[¿¼ÑÐ] 265Çóµ÷¼Á +12 ·ç˵ËýÔçÍüÁË 2026-04-10 13/650 2026-04-10 18:56 by chemisry
[ÂÛÎÄͶ¸å] mdpiСÐÞrvrʱ¼äËÄÎåÌìÁË 20+3 ¹þ¹þhigh 2026-04-08 5/250 2026-04-10 16:02 by ±±¾©À³ÒðÈóÉ«
[¿¼ÑÐ] 298Çóµ÷¼Á +13 ¶¤¶£ß˶¬¹Ï 2026-04-09 13/650 2026-04-10 15:49 by jiajinhpu
[¿¼ÑÐ] ²ÄÁϹ¤³Ì322 +18 ¹þ¹þ¹þºðºðºð¹þ 2026-04-07 19/950 2026-04-09 10:44 by cymywx
[¿¼ÑÐ] »úеר˶273ÇëÇóµ÷¼Á +6 ¸ýÉêÈÉÉê 2026-04-07 6/300 2026-04-08 22:41 by bljnqdcc
[¿¼ÑÐ] ²ÄÁϹ¤³ÌרҵÈÕÓïÉúÇóµ÷¼Á +9 111623 2026-04-07 9/450 2026-04-07 23:31 by Ò»Ö»ºÃ¹û×Ó?
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û